Selected HIV-1 Env Trimeric Formulations Act as Potent Immunogens in a Rabbit Vaccination Model
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selected HIV-1 Env Trimeric Formulations Act as Potent Immunogens in a Rabbit Vaccination Model
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 9, Pages e74552
Publisher
Public Library of Science (PLoS)
Online
2013-09-03
DOI
10.1371/journal.pone.0074552
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Broadly Neutralizing Antiviral Antibodies
- (2013) Davide Corti et al. Annual Review of Immunology
- Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
- (2013) Florian Klein et al. CELL
- International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II
- (2012) Leo Heyndrickx et al. PLoS One
- Mixed Adjuvant Formulations Reveal a New Combination That Elicit Antibody Response Comparable to Freund's Adjuvants
- (2012) Rachel P. J. Lai et al. PLoS One
- HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120
- (2012) James M. Kovacs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Broadly neutralizing antibodies against HIV-1: Templates for a vaccine
- (2012) Marit J. van Gils et al. VIROLOGY
- An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV
- (2011) Jennifer D. Watkins et al. PLoS One
- Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
- (2011) X. Wu et al. SCIENCE
- Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01
- (2011) Anders Fomsgaard et al. VACCINE
- HIV vaccine development: Challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem
- (2011) Wayne C. Koff VACCINE
- Development of standard operating procedures to obtain longitudinal vaginal specimens from nulliparous rabbits as part of HIV vaccine mucosal immunogenicity studies
- (2010) Victor Raúl Gómez Román et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Cross‐Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression
- (2010) Zelda Euler et al. JOURNAL OF INFECTIOUS DISEASES
- Unravelling the antigenic landscape of the HIV-1 subtype A envelope of an individual with broad cross-neutralizing antibodies using phage display peptide libraries
- (2010) Tessa Dieltjens et al. JOURNAL OF VIROLOGICAL METHODS
- Breadth of Neutralizing Antibodies Elicited by Stable, Homogeneous Clade A and Clade C HIV-1 gp140 Envelope Trimers in Guinea Pigs
- (2010) J. P. Nkolola et al. JOURNAL OF VIROLOGY
- Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1
- (2010) M. Pancera et al. JOURNAL OF VIROLOGY
- Rapid Escape from Preserved Cross-Reactive Neutralizing Humoral Immunity without Loss of Viral Fitness in HIV-1-Infected Progressors and Long-Term Nonprogressors
- (2010) M. J. van Gils et al. JOURNAL OF VIROLOGY
- Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
- (2010) Hugo Mouquet et al. NATURE
- Conserved structural elements in the V3 crown of HIV-1 gp120
- (2010) Xunqing Jiang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1
- (2010) R. Pejchal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
- (2010) T. Zhou et al. SCIENCE
- Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
- (2009) Xiaodong Xiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables
- (2009) N. A. Doria-Rose et al. JOURNAL OF VIROLOGY
- A Novel Liposome-Based Adjuvant CAF01 for Induction of CD8+ Cytotoxic T-Lymphocytes (CTL) to HIV-1 Minimal CTL Peptides in HLA-A*0201 Transgenic Mice
- (2009) Gregers Jacob Gram et al. PLoS One
- Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1
- (2009) Yun (Kenneth) Kang et al. VACCINE
- Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
- (2009) Ann J. Hessell et al. PLoS Pathogens
- Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
- (2008) Else Marie Agger et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started